Get startedLog in
    Picture of Kobayashi Pharmaceutical Co logo

    4967 — Kobayashi Pharmaceutical Co Cashflow Statement

    0.000.00%
    jp flag iconLast trade - 00:00
    Consumer DefensivesConservativeMid CapFalling Star
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Kobayashi Pharmaceutical Co, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.

    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    2025
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:YuhoYuhoYuhoYuhoTanshin
    Standards:
    JAS
    JAS
    JAS
    JAS    		—
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line27,63627,95027,55913,9143,744
    Depreciation
    Amortisation
    Non-Cash Items-276-351-1,0522,5986,850
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital-9,776-1,065-14,204-13,2886,251
    Change in Accounts Receivable
    Change in Inventories
    Change in Accounts Payable
    Change in Taxes Payable
    Other Operating Cash Flow
    Cash from Operating Activities22,41931,89218,36011,24625,590
    Capital Expenditures-4,185-16,229-13,569-26,629-14,011
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items12,1761,917-6,0078,21413,857
    Acquisition of Business
    Sale of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities7,991-14,312-19,576-18,415-154
    Financing Cash Flow Items-171-193-240-263-268
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-10,377-20,759-19,463-7,768-7,921
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash20,830-2,506-19,789-13,71718,719